Clarivate (Clarivate) Total Current Assets

: $1,462 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Clarivate's total current assets for the quarter that ended in Dec. 2023 was $1,462 Mil.

Clarivate Total Current Assets Historical Data

The historical data trend for Clarivate's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarivate Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

493.08

1,147.56

1,637.20

1,395.20

1,462.20

Clarivate Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Current Assets																1,395.20	1,451.30	1,417.60	1,374.70	1,462.20

Clarivate Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Clarivate's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	370.7	+	908.3	+	0	+	183.2
	=	1,462

Clarivate's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	370.7	+	908.3	+	0	+	183.2
	=	1,462

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Clarivate (NYSE:CLVT) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Clarivate's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	370.7	-	6714.5	+	0.75 * 908.3	+	0.5 * 0
=	-5,663

Clarivate Total Current Assets Related Terms

Thank you for viewing the detailed overview of Clarivate's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarivate (Clarivate) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

16A:Germany

Address

70 St. Mary Axe, London, GBR, EC3A 8BE

Website

https://www.clarivate.com

Clarivate PLC is an information, analytics, and workflow solutions company. It operates in three segments: Academia and Government; Life Sciences and Healthcare and Intellectual Property. The company generates maximum revenue from the Academia and Government segment. The A&G segment consists of Academia and Government product group, which drives research excellence across institutions, empower researchers to tackle today's global challenges and help academic institutions and libraries improve operational efficiency and effectiveness. Geographically, it derives a majority of its revenue from the Americas.

Executives

Melanie Margolin	officer: Chief Legal Officer	1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Saurabh Saha	director	C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Henry Levy	officer: President, LS&H	70 ST. MARY AXE, LONDON X0 EC3 8BA
Bar Veinstein	officer: President, A&G	70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson	officer: President, IP Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Andrew Miles Snyder	director	111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Wendell E. Pritchett	director	TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Jonathan Gear	director, officer: Chief Executive Officer-Elect	C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton	officer: Senior VP, Finance/CAO	4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri	officer: Chief Technology Officer	70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins	officer: Executive Vice President/CFO	50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed	officer: President, Science Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Michael J Angelakis	director	40 MORRIS AVENUE, BRYN MAWR PA 19010
Heather Matzke-hamlin	officer: Acting Chief Acctg Officer	4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Steen Lomholt-thomsen	officer: Chief Revenue Officer	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE1 8EZ